NABILONE / CESAMET a synthetic THC, CB 1 & CB 2 agonist and cannabis studies completed
Overview
Nabilone is chemically related to marijuana and belongs to the class of medications called cannabinoids.
Medical Marijuana: In Canada, the United States, the United Kingdom and Mexico, nabilone is marketed as Cesamet. It was approved in 1985 by the U.S. Food and Drug Administration (FDA) for treatment of chemotherapy-induced nausea and vomiting that has not responded to conventional antiemetics.
Science and Research
Undated - Monograph ~ GENERIC NAME: NABILONE - ORAL (NAB-ih-lone)
Brand Names : Cesamet
2012 - Study ~ Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.
2012 - Study ~ Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting.
2011 - News ~ What Are Prescription Drugs That Are a Substitute for Marijuana?
2010 - Study ~ CESAMET® CII (nabilone) Capsules For Oral Administration
(Archived drug label)
2010 - Study ~ A
randomized, double-blinded, crossover pilot study assessing the effect
of nabilone on spasticity in persons with spinal cord injury.
2009 - Study ~ Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation
2009 - Study ~ The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial.
2009 - Study ~ Emerging strategies for exploiting cannabinoid receptor agonists as medicines.
2009 - Study ~ A pilot study using nabilone for symptomatic treatment in Huntington's disease.
2009 - Study ~ The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD).
2008 - Study ~ Cannabinoids in the management of difficult to treat pain
2008 - Study ~ Nabilone for the treatment of pain in fibromyalgia.
2008 - Study ~ Nabilone for the treatment of paraneoplastic night sweats: a report of four cases
2008 - News ~ Science: Nabilone effective in the treatment of night sweats of four patients with advanced cancer
2008 - News ~ Marijuana Derivative Called Effective in Fibromyalgia
2008 - News ~ Marijuana-Based Drug Reduces Fibromyalgia Pain, Study Suggests
2008 - Study ~ Two New Approaches for Fibromyalgia
2007 - Study ~ Cesamet (nabilone) capsule
2007 - Study ~ Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis.
2007 - Study ~ Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances.
2007 - News ~ Synthetic Cannabis for Fibromyalgia Pain?
2007 - News ~ Nabilone relieves many advanced Ca symptoms2006 - Study ~ Nabilone significantly reduces spasticity-related pain
2006 - Study ~ The synthetic cannabinoid nabilone improves pain and symptom management in cancer patients
2006 - Study ~ Synthetic cannabinomimetic nabilone on patients with chronic pain
2006 - Study ~ The synthetic cannabinoid nabilone improves pain and symptom management in cancer patients
2006 - Study ~ The synthetic cannabinoid nabilone improves pain and symptom management in cancer patients
2006 - Study ~ Nabilone improves pain and symptom management in cancer patients
2006 - Study ~ Synthetic cannabinomimetic nabilone on patients with chronic pain
2006 - Letter ~ Nabilone Could Treat Chorea and Irritability in Huntington’s Disease
2006 - News ~ 2nd synthetic marijuana drug OK'd for chemo effects
2003 - Study ~ Therapeutic potential of cannabinoids in CNS disease.
2002 - Study ~ Cannabinoids and multiple sclerosis.
2001 - Study ~ Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study.
2000 - Study ~ Cannabis and cannabinoids: pharmacology and rationale for clinical use
1999 - Study ~ Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors.
1995 - Study ~ Nabilone in the treatment of multiple sclerosis.
1995 - Letter ~ Effect of nabilone on nausea and vomiting after total abdominal hysterectomy
1987 - Study ~ Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.
1987 - Study ~ A species comparison of the toxicity of nabilone, a new synthetic cannabinoid.
1987 - Study ~ Species specificity in the metabolism of nabilone. Relationship between toxicity and metabolic routes.
1987 - Study ~ A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea.1986 - Study ~ Nabilone: an alternative antiemetic for cancer chemotherapy.
1986 - Study ~ Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double blind study.
1986 - Study ~ Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis.
1985 - Study ~ A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy.
1984 - Study ~ Acute Effects of Natural and Synthetic Cannabis Compounds on Prolactin Levels in anesthetized cats.
1983 - Study ~ Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
1983 - Study ~ Comparison of bronchial effects of nabilone and terbutaline in healthy and asthmatic subjects.
1982 - Study ~ A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.
1981 - Study ~ The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety
1980 - Study ~ Cannabinoids. II. Cardiovascular Effects
1980 - Study ~ Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis.1979 - Study ~ Microbiological transformations of nabilone, a synthetic cannabinoid.
1979 - Study ~ Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.